FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, namely to a method of treating a human subject having cancer, expressing CD25, comprising a step of administering to a subject a human anti-CD25 antibody, wherein said subject has a solid tumour, wherein said antibody does not inhibit binding of interleukin-2 (IL-2) with CD25.
EFFECT: invention enables to treat solid tumours.
30 cl, 76 dwg, 3 tbl
| Title |
Year |
Author |
Number |
| NOVEL VERSIONS OF INTERLEUKIN-2 FOR TREATING CANCER |
2020 |
- Li Yue-Sheng
- Rui Lingyun
- Xu Jing
|
RU2833537C2 |
| IMMUNOCYTOKINES AND THEIR USE |
2021 |
- Wu Ellen
- Wu Xiaoyun
- Wakefield John
|
RU2818371C1 |
| ANTIBODY BINDING HUMAN IL-4R, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL APPLICATION THEREOF |
2019 |
- Lyao, Chen
- Syuj, Tszupen
- Tszyan, Tszyakhua
- Chzhan, Lyanshan
- Tsyan, Syuemin
- Ten, Fej
|
RU2779649C1 |
| ANTIBODY AGAINST IL-5, ITS ANTIGEN-BINDING FRAGMENT AND ITS MEDICAL USE |
2018 |
- In, Khua
- Shi, Tszinpin
- Van, Ifan
- Khu, Tsiyue
- Ge, Khu
- Tao, Vejkan
|
RU2772716C2 |
| ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION |
2018 |
- Surh, Charles D.
- Lee, Jun-Young
|
RU2745451C1 |
| METHODS FOR PRODUCING CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR |
2015 |
- Bedoya Felipe
- Ghassemi Saba
- June Carl H.
- Levine Bruce L.
- Melenhorst Jan J.
- Milone Michael C.
- Powell Daniel J. Jr.
- Zheng Zoe
|
RU2751362C2 |
| IMMUNE CELLS EXPRESSING INVERSE UNIVERSAL CHIMERIC ANTIGEN RECEPTOR, FOR TARGETING VARIOUS MULTIPLE ANTIGENS AND METHOD FOR PRODUCTION AND USE THEREOF FOR TREATING CANCER, INFECTIONS AND AUTOIMMUNE DISEASES |
2019 |
|
RU2824391C2 |
| ANTI-IL-17A ANTIBODY AND USE THEREOF |
2019 |
- Yao Jian
- Meng Dan
- Feng Hui
- Yao Sheng
- Wu Hai
|
RU2816204C2 |
| NOVEL MOLECULES OF AGONISTIC ANTI-TNFR2 ANTIBODIES |
2019 |
- Frendeus, Bjorn
- Teige, Ingrid
- MÅ
- Rtensson, Linda
- Holmkvist, Petra
|
RU2840049C2 |
| FUSION PROTEIN COMPRISING IL-2 PROTEIN AND CD80 PROTEIN AND ITS USE |
2019 |
|
RU2811541C2 |
